Zobrazeno 1 - 10
of 24
pro vyhledávání: '"ZSUZSA S. KOCSIS"'
Autor:
László Gesztesi, Zsuzsa S. Kocsis, Kliton Jorgo, Georgina Fröhlich, Csaba Polgár, Péter Ágoston
Publikováno v:
Prostate Cancer, Vol 2024 (2024)
The aim of the study was to compare the side effects of high-dose-rate brachytherapy (HDRBT) and low-dose-rate brachytherapy (LDRBT), with a particular focus on the effects on sexual functions and sexual well-being (PROMOBRA study, NCT02258087). Loca
Externí odkaz:
https://doaj.org/article/79247b246cef45f1a07aa7d0d8a80827
Autor:
Zsuzsa S. Kocsis, Tibor Major, Csilla Pesznyák, Dalma Mihály, Gábor Stelczer, Márta Kun-Gazda, Gyöngyi Farkas, Gábor Székely, Péter Ágoston, Kliton Jorgo, László Gesztesi, Csaba Polgár, Zsolt Jurányi
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Brachytherapy (BT) and external beam radiotherapy (EBRT) apply different dose rates, overall treatment times, energies and fractionation. However, the overall impact of these variables on the biological dose of blood is neglected. As the siz
Externí odkaz:
https://doaj.org/article/8de8956ec6ed449895b3bb069dfdc5a2
Autor:
Zsuzsa S. Kocsis, Gyöngyi Farkas, András Bajcsay, Márta Kun-Gazda, József Lövey, Gyula Ostoros, Tamás Pócza, András Herein, Katalin Ladányi, Gábor Székely, Zsolt Markóczy, Zoltán Takácsi-Nagy, Csaba Polgár, Zsolt Juranyi
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
Due to the profound difference in radiosensitivity of patients and various side effects caused by this phenomenon, a radiosensitivity marker is needed. Prediction by a marker may help personalise the treatment. In this study, we tested chromosomal ab
Externí odkaz:
https://doaj.org/article/e3c230458481433faae4e161f5e78458
Autor:
Polgár, Botond Bukovszky, János Fodor, Erika Tóth, Zsuzsa S. Kocsis, Ferenc Oberna, Örs Ferenczi, Csaba
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 13; Pages: 4255
Background: Oral or laryngeal leukoplakia has an increased risk for malignant transformation but the risk of the two anatomical sites has not been compared to each other yet. Materials and Methods: Clinical data of 253 patients with leukoplakia (oral
Autor:
Gyöngyi Farkas, Gábor Székely, Veronika Goda, Krisztián M. Kállay, Zsuzsa S. Kocsis, Katalin Szakszon, Gábor Benyó, Dániel Erdélyi, Zoltán Liptai, Katalin Csordás, Gabriella Kertész, István Szegedi, Gergely Kriván, Zoltán Takácsi‐Nagy, Csaba Polgár, Zsolt Jurányi
Publikováno v:
European Journal of Haematology.
Autor:
Francesco D'Errico, Géza Sáfrány, Csilla Pesznyák, Zsuzsa S Kocsis, Tímea Hülber, Eniko Kis, Judit Németh
Publikováno v:
International Journal of Radiation Biology. 97:1470-1484
PURPOSE Automatizing the scoring of the cytokinesis-blocked micronucleus assay spares a lot of valuable time. The dose-effect relationship can be applied reliably for dose estimation if the quality of the slides is the same from the perspective of th
Autor:
Csilla Pesznyák, Zsolt Jurányi, Gábor J. Székely, Csaba Polgár, Zsuzsa S Kocsis, Tamás Pócza, Tibor Major, Gyöngyi Farkas, Dalma Mihály
Publikováno v:
Journal of Radiation Research
The aim of this study was to investigate the radiobiological effects of flattening filter (FF) and flattening filter-free (FFF) modes of linear electron accelerators and to understand whether there is any difference between the effects of these modes
Autor:
Péter, Ágoston, Kliton, Jorgo, Zsuzsa S, Kocsis, Levente, Varga, László, Gesztesi, Zoltán, Takácsi-Nagy, Csaba, Polgár
Publikováno v:
Magyar onkologia. 65(4)
Radical cystectomy is the gold standard treatment in localized muscle-invasive bladder cancer according to today's guidelines. However, in many cases, surgery is not possible due to the patient's general condition, or the patient refuses bladder remo
Autor:
GYÖNGYI FARKAS, ZSUZSA S. KOCSIS, GÁBOR SZÉKELY, ISTVÁN KENESSEY, CSABA POLGÁR, ZSOLT JURÁNYI
Publikováno v:
Anticancer research. 42(2)
Cytogenetic analysis of chromosomes in blood lymphocytes can be used to reveal biomarkers of tumor risk. The frequency of chromosomal aberrations (CAs) appears to correlate with the later incidence of cancer.In our work, a total of 515 healthy Hungar
Autor:
Katalin Balázs, Zsuzsa S. Kocsis, Péter Ágoston, Kliton Jorgo, László Gesztesi, Gyöngyi Farkas, Gábor Székely, Zoltán Takácsi-Nagy, Csaba Polgár, Géza Sáfrány, Zsolt Jurányi, Katalin Lumniczky
Publikováno v:
Cancers; Volume 14; Issue 13; Pages: 3058
Background: The development of cancer and anti-tumor therapies can lead to systemic immune alterations but little is known about how long immune dysfunction persists in cancer survivors. Methods: We followed changes in the cellular immune parameters